Abstract:Significance: Hypertrophic scarring is a challenging issue for patients and clinicians. The prevalence of hypertrophic scarring can be up to 70% after burns, and patients suffer from pain, itching, and loss of joint mobility. To date, the exact mechanisms underlying hypertrophic scar formation are unclear, and clinical options remain limited. Recent Advances: Several studies have demonstrated that pathological scars are a type of hyperactive vascular response to wounding. Scar regression has been found to be accompanied by microvessel occlusion, which causes severe hypoxia, malnutrition, and endothelial dysfunction, suggesting the essential roles of microvessels in scar regression. Therefore, interventions that target the vasculature, such as intense pulsed light, pulsed dye lasers, vascular endothelial growth factor antibodies, and Endostar, represent potential treatments. In addition, the mass of scar-associated collagen is usually not considered by current treatments. However, collagen-targeted therapies such as fractional CO2 laser and collagenase have shown promising outcomes in scar treatment. Critical Issues: Traditional modalities used in current clinical practice only partially target scar-associated microvessels or collagen. As a result, the effectiveness of current treatments is limited and is too often accompanied by undesirable side effects. The formation of scars in the early stage is mainly affected by microvessels, whereas the scars in later stages are mostly composed of residual collagen. Traditional therapies do not utilize specific targets for scars at different stages. Therefore, more precise treatment strategies are needed. Future Directions: Scars should be classified as either "vascular-dominant" or "collagen-dominant" before selecting a treatment. In this way, strategies that are vascular-targeted, collagen-targeted, or a combination thereof could be recommended to treat scars at different stages.

Direct And Indirect Roles Of Macrophages In Hypertrophic Scar Formation

The role of macrophages in the formation of hypertrophic scars and keloids

Research progress of renin angiotensin system on hypertrophic scar

Biological approaches for hypertrophic scars

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

The Clinical Dynamic Changes Of Macrophage Phenotype And Function In Different Stages Of Human Wound Healing And Hypertrophic Scar Formation

SHH induces macrophage oxidative phosphorylation and efferocytosis to promote scar formation

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring.

[Research Advances on the Role and Mechanism of Inflammatory Response in the Formation of Hypertrophic Scars and Keloids].

[Research advances on pharmacological interventions for hypertrophic scar]

The Roles of Inflammation in Keloid and Hypertrophic Scars

Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars

Vascular and Collagen Target: A Rational Approach to Hypertrophic Scar Management

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis

Inflammation in Wound Healing and Pathological Scarring

Role of Mitogen-Activated Protein Kinases in the Formation of Hypertrophic Scar with Model of Lipopolysaccharide Stimulated Skin Fibroblast Cells

Keloids and hypertrophic scars: update and future directions.

Emerging Role of IL-10 in Hypertrophic Scars

Epithelial–mesenchymal transition in the formation of hypertrophic scars and keloids